BookPage 3 of 10

Page3

 
Pre-Test - Practice Assessment
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
How often do you incorporate bevacizumab into the treatment regimens of patients with recurrent, persistent, or metastatic cervical cancer? (please rate based on the following scale:  1 = Never; 2 = Rarely; 3 = Sometimes; 4 = Often;  5 = Always)
Bevacizumab